13F Pro Quality Score
Limited institutional coverage
Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 12 institutional filers currently hold this stock.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Reported revenue, net income and operating margin by fiscal year, from BGM Group Ltd.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 20-F | $37.9M | $-19.9M | -33.2% |
| FY 2024 | 20-F/A | $25.1M | $-1.4M | -2.3% |
| FY 2023 | 20-F/A | $46.5M | $-7.8M | -5.6% |
| FY 2022 | 20-F/A | $64.9M | $1.1M | 3.2% |
| FY 2021 | 20-F/A | $57.1M | $3.1M | 4.2% |
| FY 2020 | 20-F | $50.0M | $5.1M | 9.6% |
BGM Group Ltd. (BGM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. BGM is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 12 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), BGM Group Ltd. reports quarterly revenue of $37.9M, net income of $-19.9M, an operating margin of -33.2%. Top institutional holders of BGM by reported 13-F value include GEODE CAPITAL MANAGEMENT, XTX Topco Ltd, UBS Group AG, based on the most recent SEC filings. BGM trades on the Nasdaq exchange and files with the SEC under CIK 1779578. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BGM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BGM Group Ltd. directly from SEC EDGAR.